Cardiovascular Systems Valuation

Cardiovascular Systems Investor Information

About 90.0% of the company shares are held by institutions such as insurance companies. The book value of Cardiovascular Systems was currently reported as 5.7. The company has Price/Earnings (P/E) ratio of 724.24. Cardiovascular Systems recorded a loss per share of 0.96. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 26th of February 2009. Based on the key indicators related to Cardiovascular Systems' liquidity, profitability, solvency, and operating efficiency, Cardiovascular Systems is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.

Cardiovascular Systems Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cardiovascular Systems has an asset utilization ratio of 73.21 percent. This signifies that the Company is making $0.73 for each dollar of assets. An increasing asset utilization means that Cardiovascular Systems is more efficient with each dollar of assets it utilizes for everyday operations.

Cardiovascular Systems Ownership Allocation

Cardiovascular Systems holds a total of 42.2 Million outstanding shares. The majority of Cardiovascular Systems outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cardiovascular Systems to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cardiovascular Systems. Please pay attention to any change in the institutional holdings of Cardiovascular Systems as this could imply that something significant has changed or is about to change at the company. On April 19, 2023, Senator Tina Smith of US Senate acquired $50k to $100k worth of Cardiovascular Systems's common stock.

Cardiovascular Systems Profitability Analysis

The company reported the previous year's revenue of 236.22 M. Net Loss for the year was (36.93 M) with profit before overhead, payroll, taxes, and interest of 172.78 M.

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.